Patient-centric transformation in a dynamic world

Challenges facing the life sciences sector

The pace of change in the life sciences industry has never been greater. Companies are under pressure to keep up with significant levels of market activity including M&A, technological advancement coupled with enhanced customer expectations, and heightened disruption from non-traditional competitors. At Gate One, we have a strong track record of patient-centric transformations in the life sciences sector, helping organisations to overcome these challenges.

M&A turmoil

For many organisations, M&A is a means of quickly gaining a competitive edge. The right opportunity enables life sciences businesses to accelerate research and development (R&D), while restocking their shrinking product pipelines. However, merging, acquiring, separating or divesting all come with their own unique challenges. Anticipating and resolving these quickly is critical to preserving shareholder value.

Technological advancement

To stay ahead of the curve and satisfy customer expectations, organisations need to be able to deliver tailored therapies, support solutions and customer engagement (patient and HCP) – all of which are heavily dependent on optimising data and a wide variety of digital and technology solutions. The regulatory backdrop presents further complexity that must be factored into both design and delivery.

Non-traditional competitors

Disruption from non-traditional competitors is increasing the size and complexity of the industry. This is driving organisations to shift from a more focused portfolio approach to patient and customer-centric innovation, which brings with it the need to design, implement and optimise new working practices.

Our Credentials 

We are privileged to be working with some of the UK’s largest and most innovative life sciences organisations on their complex change programmes. View some of our client stories here.

Delivering a multi-billion-pound acquisition and integration

Defining and regionally implementing integration support activities as part of a major pharmaceutical acquisition.

Driving global growth through digital for a global pharma

Setting the strategy and delivering the rollout of a new customer engagement system with world-class technology.

Stepping up marketing

Establishing an integrated data-driven marketing capability to deliver improved ROI and smarter ways of working.

Meet some of our team

Dr Pamela Walker
Dr Pamela Walker
Life sciences lead
Simon Dennis
Simon Dennis
Umbar Shakir
Umbar Shakir
Client director
Harry Mulheran
Harry Mulheran

If you would like to speak to us about how we can help you deliver value to your customers, please contact Dr Pamela Walker.